Crinetics Pharmaceuticals, Inc. cotiza a 84.95 USD y tiene una capitalización bursátil de $9.0B. En los últimos 12 meses ha facturado $42M con un margen de flujo de caja libre del -4985.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor t…
| Periodo | 2026-11 |
|---|---|
| Real | — |
| Estimado | $-1.06 |
| Sorpresa | — |
| Métrica | CRNX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 86.0% | 57.0% | +29.0% |
| Operating Margin | -6714.8% | -38.6% | -6676.2% |
| Net Margin | -6046.2% | -33.6% | -6012.7% |
| FCF Margin | -4985.5% | -13.9% | -4971.6% |
| ROE | -46.9% | -40.4% | -6.5% |
| ROA | -41.3% | -32.0% | -9.3% |
| Current Ratio | 12.32 | 2.84 | +9.48 |
| Debt / Equity | — | 0.28 | — |